|
Market Cap (17-May) $41,071,320 (780th) |
Close (30-Jun) $0.081 |
Volume (30-Jun) 2,818,974 |
Shortsold (13-Feb) 21,991 (0.00%) (605th) |
|
52w High $0.063 |
52w Low $0.037 |
P/E - |
EPS -0.01 |
PTX released this announcement to the ASX on 27 February 2023, 15:22. The announcement is not marked as price sensitive, and is 10 page(s) in length and 1.08MB in size.
You can view all announcements from PTX and see how they appear on a price chart on the announcements page.
At the date of this announcement, PTX was 0.084% short sold according to ASIC data. It was ranked the 465th most shorted stock on the ASX. It remains ranked 605th as of the latest reported data (13 February 2024).
| Other Recent Announcements from PTX | |
|---|---|
| Application for quotation of securities - PTX | 14 June 2023, 15:38 |
| Two PTX abstracts accepted at prestigious ISCT conference | 16 May 2023, 8:59 |
| Initial Director's Interest Notice | 15 May 2023, 14:31 |
| Revised Securities Trading Policy | 27 February 2023, 15:22 |
| Appendix 4D and Half Year Financial Report | 24 February 2023, 13:38 |
| Notification of Expiry of Listed Options | 22 February 2023, 18:21 |
| Application for quotation of securities - PTX | 9 February 2023, 14:39 |
You must be logged in to post a reply.
Prescient Therapeutics 